Continuous monitoring of uterine contractions to control intra-amniotic administration of prostaglandin F2 alpha for therapeutic and missed abortion. 1981

C J Roux, and H J Odendaal

Intra-amniotic prostaglandin F2 alpha (PGF2 alpha) was administered to 10 patients for midtrimester therapeutic abortion and to 20 patients for missed abortion. An epidural catheter was placed into the amniotic cavity and the other end was connected to a physiological pressure transducer to measure the uterine contractions continuously. The dosage was adjusted according to the uterine contractions, and was therefore individualized for each patient. Half the patients with therapeutic abortion required PGF2 alpha 30 mg or less, and only 20% of patients with missed abortion needed more than 30 mg. Complications such as uterine cervical lacerations could be prevented by administration of the correct dosage of prostaglandin in each case.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000030 Abortion, Missed The retention in the UTERUS of a dead FETUS two months or more after its DEATH. Abortions, Missed,Missed Abortion,Missed Abortions
D000032 Abortion, Therapeutic Abortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed) Therapeutic Abortion,Abortions, Therapeutic,Therapeutic Abortions
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

C J Roux, and H J Odendaal
September 1973, American journal of obstetrics and gynecology,
C J Roux, and H J Odendaal
October 1973, American journal of obstetrics and gynecology,
C J Roux, and H J Odendaal
December 1972, The Journal of reproductive medicine,
C J Roux, and H J Odendaal
January 1988, Clinical and experimental obstetrics & gynecology,
C J Roux, and H J Odendaal
January 1988, Advances in contraceptive delivery systems : CDS,
C J Roux, and H J Odendaal
January 1986, Biological research in pregnancy and perinatology,
C J Roux, and H J Odendaal
March 1982, Ugeskrift for laeger,
Copied contents to your clipboard!